| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/10/2006 | US6984384 A biodrug mixture contains a preheated fusion protein,comprising heat shock protein, glucose-regulated protein and immuogens; antigrowth agents; cancer, tuberculosis infection |
| 01/10/2006 | CA2383036C Solid lipid formulations |
| 01/10/2006 | CA2363842C Chewable soft capsule having improved ingestion property and method for producing the same |
| 01/10/2006 | CA2246691C Aqueous product comprising oil microdroplets stabilized by in-situ polymerized vinyl monomer and a thickening agent |
| 01/10/2006 | CA2198630C Acetaminophen sustained-release formulation |
| 01/10/2006 | CA2189831C Dna-based vaccination of fish by immersion |
| 01/09/2006 | CA2511718A1 Tablet excipient |
| 01/05/2006 | WO2006002419A2 Cross-linked cellulose ii |
| 01/05/2006 | WO2006002195A2 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 01/05/2006 | WO2006002067A1 Composition and method using local application of lipophilic lathyrogens in sustained release formulations |
| 01/05/2006 | WO2006002050A1 Phospholipid compositions and methods for their preparation and use |
| 01/05/2006 | WO2006001963A1 Pharmaceutical compositions comprising cyclosporins |
| 01/05/2006 | WO2006001046A1 Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses |
| 01/05/2006 | WO2006000920A2 Dimensional analysis of saccharide conjugates with gpc & sec-mals |
| 01/05/2006 | WO2006000913A1 Method for sterile filtration of viscous pharmaceutical compositions |
| 01/05/2006 | WO2006000592A1 Use of ether group-containing polymers as solubilizers |
| 01/05/2006 | WO2005112974A3 Peptide-modified polyurethane compositions and associated methods |
| 01/05/2006 | WO2005077370A8 Aqueous solution preparation containing camptothecins |
| 01/05/2006 | WO2005072745A3 Aqueous solutions comprising prednisolone and a cyclodextrin derivative |
| 01/05/2006 | WO2005065282A3 Remote magnetically induced treatment of cancer |
| 01/05/2006 | WO2005055980A3 Polymalic acid-based multifunctional drug delivery system |
| 01/05/2006 | WO2005051347A3 A simple process and formulation for making taste- masked ibuprofen liquid preparations and similar good-tasting preparation of other pharmaceutically active or bitter, poor tasting compounds for the production of liquid preparations |
| 01/05/2006 | WO2005037320A3 Process for preparing polysaccharide-protein conjugate vaccines |
| 01/05/2006 | WO2005000357A3 Chemical combination and method for increasing delivery of coenzyme q 10 |
| 01/05/2006 | WO2004078146A3 Trans-membrane-antibody induced inhibition of apoptosis |
| 01/05/2006 | WO2004071453A3 Compositions and methods for treatment of pouchitis |
| 01/05/2006 | WO2004040997A3 Multiple component food product useful for delivering glucosamine and/or nacetyl-d-glucosamine |
| 01/05/2006 | US20060004456 Intervertebral disc treatment devices and methods |
| 01/05/2006 | US20060004026 Compositions for ameliorating attention-deficient/hyperactivity disorder |
| 01/05/2006 | US20060003965 N-acetyl-d-glucosamine (nag) supplemented food products and beverages |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003949 Freeze-dried preparation of stabilized anthracycline compound |
| 01/05/2006 | US20060003943 Protease enzyme inhibitors |
| 01/05/2006 | US20060003923 Stability, reduced toxicity; covalently linked imidazole functionality |
| 01/05/2006 | US20060003012 Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| 01/05/2006 | US20060003011 Pharmaceutical compositions of drugs and neutralized acidic polymers |
| 01/05/2006 | US20060003009 Slow release protein polymers |
| 01/05/2006 | US20060003002 Pharmaceutical compositions with synchronized solubilizer release |
| 01/05/2006 | US20060002996 Stable spray-dried protein formulations |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | US20060002984 Diet composition and method |
| 01/05/2006 | US20060002983 Muscle building preparation |
| 01/05/2006 | US20060002966 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| 01/05/2006 | US20060002955 predisposing agent; lignosulfonate, gallic acid, lignosulfonate, gallic acid, yeast extract; a carbon-skeleton-energy component; and a vitamin-cofactor; control of soil born pests and pathogens; improvement in soil fertility mineral release, water filtration; neutralization and/or degradation of toxins |
| 01/05/2006 | US20060002946 Targeted immunogens |
| 01/05/2006 | US20060002942 Calicheamicin conjugates |
| 01/05/2006 | US20060002940 Method of immunotherapy |
| 01/05/2006 | US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators) |
| 01/05/2006 | US20060002908 Bifidobacterium in the treatment of inflammatory disease |
| 01/05/2006 | US20060002905 Mutant forms of EtxB and CtxB and their use as carriers |
| 01/05/2006 | US20060002894 Method for introducing a biological molecule using a viral envelope and composition and system therefor |
| 01/05/2006 | US20060002891 Cytomodulating conjugates of members of specific binding pairs |
| 01/05/2006 | US20060002874 Topical pharmaceutical composition to treat hyperpigmentation of the skin |
| 01/05/2006 | US20060002861 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist |
| 01/05/2006 | US20060002855 Targeted combination immunotherapy of cancer and infectious diseases |
| 01/05/2006 | US20060002854 Conjugate of therapeutic moiety linked to peptide having the amino acid sequence CGKRK, length < 400 residues, or a conservative variant or peptidomimetic; anticarcinogenic, -tumor agents; tissue-targeted therapy; side effect reduction; binds cognate receptor; angiogenesis inhibitors |
| 01/05/2006 | DE102004028977A1 Pellet, useful to prepare pharmaceutical preparations and administer therapeutically and/or prophylactically active substances e.g. antirheumatic-, antidiabetic- or antiallergic- drug, comprises a water-soluble carrier e.g. mannitol |
| 01/05/2006 | DE102004028284A1 Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin Controlled matrix transdermal therapeutic system based on a hot melt adhesive for use of norelgestromin |
| 01/05/2006 | CA2612006A1 Phospholipid compositions and methods for their preparation and use |
| 01/05/2006 | CA2578682A1 Composition for antianxiety drug containing vegetable essence ingredient as active ingredient, percutaneous-absorption-type antianxiety drug employing the composition, and processes for producing these |
| 01/05/2006 | CA2572127A1 Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses |
| 01/05/2006 | CA2571565A1 Dimensional analysis of saccharide conjugates with gpc & sec-mals |
| 01/05/2006 | CA2571341A1 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 01/05/2006 | CA2570976A1 Methods of treatment of endobronchial infections |
| 01/05/2006 | CA2570312A1 Use of ether group-containing polymers as solubilizers |
| 01/04/2006 | EP1611884A1 Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 01/04/2006 | EP1611883A1 Composition for ophthalmic use |
| 01/04/2006 | EP1611881A1 Pregelatinized starch in a controlled release formulation |
| 01/04/2006 | EP1611173A1 Polymeric modifiers and pharmaceutical compositions |
| 01/04/2006 | EP1611170A2 Macromolecules auto-assembled and photopolymerised around carbon nanotubes a method for production and application thereof |
| 01/04/2006 | EP1611155A2 Method and compositions for conversion of antibody activity |
| 01/04/2006 | EP1611093A2 Modified transferrin fusion proteins |
| 01/04/2006 | EP1610825A2 Methods for rational pegylation of proteins |
| 01/04/2006 | EP1610824A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 01/04/2006 | EP1610822A1 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 01/04/2006 | EP1610820A1 High concentration antibody and protein formulations |
| 01/04/2006 | EP1610818A1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610809A2 Vault and vault-like carrier molecules |
| 01/04/2006 | EP1610808A2 Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
| 01/04/2006 | EP1610805A2 Thiol-mediated drug attachment to targeting peptides |
| 01/04/2006 | EP1610798A2 Estradiol metabolites for the treatment of pulmonary hypertension |
| 01/04/2006 | EP1610777A1 Oral suspension of tegaserod |
| 01/04/2006 | EP1610764A1 Taste-masking vehicle for coated oxazolidinone particles |
| 01/04/2006 | EP1610761A2 Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
| 01/04/2006 | EP1610752A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same |
| 01/04/2006 | EP1610751A2 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
| 01/04/2006 | EP1610742A2 Methods and compositions for administration of trpv1 agonists |
| 01/04/2006 | EP1469811A4 Methods and compositions for oxygen transport comprising modified hemoglobin in plasma |
| 01/04/2006 | EP1320412B1 Microcapsule powder |
| 01/04/2006 | EP1284754B1 Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts |
| 01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
| 01/04/2006 | EP1202744B1 PRODUCTION OF rhPBGD |
| 01/04/2006 | EP1178834B1 Controlled release of growth factors from heparin containing matrices |
| 01/04/2006 | EP1150995B1 A synthetic peptide disturbing intracellular signaling |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP1131051B1 Pressurised metered dose inhalers (mdi) |
| 01/04/2006 | EP0977562B1 Methods and compositions for delivery of taxanes |
| 01/04/2006 | EP0946217B1 Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents |
| 01/04/2006 | EP0932399B1 Water soluble paclitaxel prodrugs |